AAAAAA
Results: 1-25/51
Authors:
Harkin, A
Morris, K
Kelly, JP
O'Donnell, JM
Leonard, BE
Citation: A. Harkin et al., Modulation of MK-801-induced behaviour by noradrenergic agents in mice, PSYCHOPHAR, 154(2), 2001, pp. 177-188
Authors:
Leonard, BE
Citation: Be. Leonard, Stress, norepinephrine and depression, J PSYCH NEU, 26, 2001, pp. S11-S16
Authors:
Harkany, T
O'Mahony, S
Keijser, J
Kelly, JP
Konya, C
Borostyankoi, ZA
Gorcs, TJ
Zarandi, M
Penke, B
Leonard, BE
Luiten, PGM
Citation: T. Harkany et al., beta-amyloid((1-42))-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex, NEUROBIOL D, 8(4), 2001, pp. 667-678
Authors:
Ryan, PM
Kelly, JP
Chambers, PL
Leonard, BE
Citation: Pm. Ryan et al., The toxicity profile of a single dose of paroxetine: An alternative approach to acute toxicity testing in the rat, PHARM TOX, 88(2), 2001, pp. 59-66
Authors:
Leonard, BE
Citation: Be. Leonard, Antidepressants: Developments for the 21st century, HUM PSYCHOP, 16(1), 2001, pp. 1-1
Authors:
Leonard, BE
Citation: Be. Leonard, Bipolar medications: mechanisms of action, IRIS J PS M, 18(3), 2001, pp. 112-112
Authors:
Leonard, BE
Citation: Be. Leonard, Changes in the immune system in depression and dementia: causal or co-incidental effects?, INT J DEV N, 19(3), 2001, pp. 305-312
Authors:
Leonard, BE
Citation: Be. Leonard, The immune system, depression and the action of antidepressants, PROG NEUR-P, 25(4), 2001, pp. 767-780
Authors:
Harkin, A
Connor, TJ
Mulrooney, J
Kelly, JP
Leonard, BE
Citation: A. Harkin et al., Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats, LIFE SCI, 68(12), 2001, pp. 1367-1382
Authors:
Leonard, BE
Citation: Be. Leonard, Brain cytokines and the psychopathology of depression, MIL DRUG TH, 2001, pp. 109-120
Authors:
Connor, TJ
Harkin, A
Kelly, JP
Leonard, BE
Citation: Tj. Connor et al., Olfactory bulbectomy provokes a suppression of interleukin-1 beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment, NEUROIMMUNO, 7(1), 2000, pp. 27-35
Authors:
Leonard, BE
Citation: Be. Leonard, Noradrenaline and depression, REV CONT PH, 11(5), 2000, pp. 257-266
Authors:
Leonard, BE
Citation: Be. Leonard, Peripheral markers of depression, CUR OPIN P, 13(1), 2000, pp. 61-68
Authors:
Naughton, M
Mulrooney, JB
Leonard, BE
Citation: M. Naughton et al., A review of the role of serotonin receptors in psychiatric disorders, HUM PSYCHOP, 15(6), 2000, pp. 397-415
Authors:
Cryan, JF
Leonard, BE
Citation: Jf. Cryan et Be. Leonard, 5-HT1A and beyond: The role of serotonin and its receptors in depression and the antidepressant response, HUM PSYCHOP, 15(2), 2000, pp. 113-135
Authors:
Leonard, BE
Citation: Be. Leonard, Stress, depression and the immune system, STRESS MED, 16(3), 2000, pp. 133-137
Authors:
Nolan, Y
Connor, TJ
Kelly, JP
Leonard, BE
Citation: Y. Nolan et al., Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain, J NEURAL TR, 107(12), 2000, pp. 1393-1401
Authors:
Harkin, A
Nally, R
Kelly, JP
Leonard, BE
Citation: A. Harkin et al., Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta 1-adrenergic receptors in an animal model of depression, J NEURAL TR, 107(10), 2000, pp. 1213-1227
Authors:
Wrynn, AS
Sebens, JB
Koch, T
Leonard, BE
Korf, J
Citation: As. Wrynn et al., Prolonged c-Jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset, MOL BRAIN R, 76(1), 2000, pp. 7-17
Authors:
Feighner, JP
Ehrensing, RH
Kastin, AJ
Leonard, BE
Sverdlov, L
Nicolau, G
Patel, A
Hlavka, J
Abajian, H
Noble, JF
Citation: Jp. Feighner et al., A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression, J AFFECT D, 61(1-2), 2000, pp. 119-126
Authors:
Conner, TJ
Kelly, JP
Leonard, BE
Citation: Tj. Conner et al., An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats, IMMUNOPHARM, 46(3), 2000, pp. 223-235
Authors:
Leonard, BE
Citation: Be. Leonard, Evidence for a biochemical lesion in depression, J CLIN PSY, 61, 2000, pp. 12-17
Authors:
Connor, TJ
Kelliher, P
Shen, Y
Harkin, A
Kelly, JP
Leonard, BE
Citation: Tj. Connor et al., Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test, PHARM BIO B, 65(4), 2000, pp. 591-597
Authors:
Harkin, A
Kelly, JP
Frawley, J
O'Donnell, JM
Leonard, BE
Citation: A. Harkin et al., Test conditions influence the response to a drug challenge in rodents, PHARM BIO B, 65(3), 2000, pp. 389-398
Authors:
Kelliher, P
Connor, TJ
Harkin, A
Sanchez, C
Kelly, JP
Leonard, BE
Citation: P. Kelliher et al., Varying responses to the rat forced-swim test under diurnal and nocturnal conditions, PHYSL BEHAV, 69(4-5), 2000, pp. 531-539